Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Neuroendocrine Cancers – A “NET” Update from Prof. Mark Strachan
Neuroendocrine Cancers – A “NET” Update from Prof. Mark Strachan Wednesday 12th April 2023 13:30pm – 15:30pm Liberton Kirk Centre, Kirkgate, Liberton, Edinburgh, EH16 6RY Professor Strachan will be giving an update on the treatment and administration of...
High Grade Neuroendocrine Carcinoma Explained
Dr Nick Coupe, Medical Oncologist, Oxford University Hospital NHS Foundation Trust talks to Neuroendocrine Cancer UK about high grade neuroendocrine carcinomas. What is High Grade Neuroendocrine Cancer? Grade is an essential assessment and measurement of how...
INCA – New Factsheets
INCA (The International Neuroendocrine Cancer Alliance) has released six new factsheets including; genetic NET syndromes, Pheochromocytoma (pheo) and paraganglioma (para), and sporadic Pheo and para in their NETInfo multilingual library, which now offers a total of 26...